Company Overview of Fujian Normal University
Fujian Normal University is an educational institution.
Key Executives for Fujian Normal University
Fujian Normal University does not have any Key Executives recorded.
Fujian Normal University Key Developments
Verisante Technology, Inc. Enter into Collaboration with BC Cancer Agency and Fujian Normal University to Develop New Application for its Exclusively Licensed Platform Technology
Aug 7 13
Verisante Technology, Inc. announced that it has entered into a collaboration with the BC Cancer Agency and Fujian Normal University in China to develop a new application for the Company's exclusively licensed platform technology. Verisante has currently licensed technology from the BC Cancer Agency to develop its Core(TM) devices, which use an endoscope for the detection of lung, colon, gastro-intestinal and cervical cancers. This new collaboration adds an option to include nasopharyngeal cancer on the list of applications licensed from the BC Cancer Agency to Verisante. The University will be using a nasopharyngeal endoscopic laser Raman system in a study to detect cancerous lesions. Verisante is providing the University with a ClearVu Elite fluorescence endoscopy system. Dr. Haishan Zeng, a distinguished scientist in the Integrative Oncology Department at BC Cancer Agency is leading the development of a nasopharyngeal endoscopic Raman probe. Both the fluorescence imaging system and the Raman spectroscopy probe will be used in the detection and analysis of spectral data collected on patients in China at the Fujian Provincial Tumor Hospital.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries